Haluk Sargın

648 total citations
25 papers, 497 citations indexed

About

Haluk Sargın is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Haluk Sargın has authored 25 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Haluk Sargın's work include Liver Disease Diagnosis and Treatment (4 papers), Thyroid Disorders and Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Haluk Sargın is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Thyroid Disorders and Treatments (4 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Haluk Sargın collaborates with scholars based in Türkiye, United States and Germany. Haluk Sargın's co-authors include Hülya Ilıksu Gözü, Mehmet Sargın, Mehmet Sargın, Fevzi Akinci, Murat Yayla, Ali Alper Yayla, B. Şimşek, Aymelek Gönenç, Adnan Menevşe and Abdülkadir Koçer and has published in prestigious journals such as The Journal of Urology, International Journal of Obesity and World Journal of Gastroenterology.

In The Last Decade

Haluk Sargın

23 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haluk Sargın Türkiye 13 286 136 91 72 38 25 497
Anna Bohdanowicz-Pawlak Poland 12 150 0.5× 97 0.7× 58 0.6× 47 0.7× 14 0.4× 33 450
Mary F. Carroll United States 7 196 0.7× 47 0.3× 81 0.9× 77 1.1× 10 0.3× 8 458
Welmoed Reitsma Netherlands 9 281 1.0× 74 0.5× 94 1.0× 58 0.8× 8 0.2× 11 642
Göksün Ayvaz Türkiye 17 311 1.1× 151 1.1× 161 1.8× 142 2.0× 13 0.3× 38 971
L Misso Italy 7 172 0.6× 111 0.8× 140 1.5× 135 1.9× 12 0.3× 12 547
Russo Russo Italy 11 103 0.4× 43 0.3× 60 0.7× 97 1.3× 22 0.6× 44 488
Renata Saucedo Mexico 16 133 0.5× 157 1.2× 156 1.7× 98 1.4× 6 0.2× 77 836
Glenn Matfin United States 13 350 1.2× 60 0.4× 188 2.1× 37 0.5× 20 0.5× 40 692
Hala Ahmadieh Lebanon 10 141 0.5× 84 0.6× 92 1.0× 79 1.1× 15 0.4× 22 454
Stylianos Kandarakis Greece 12 107 0.4× 59 0.4× 102 1.1× 37 0.5× 19 0.5× 51 785

Countries citing papers authored by Haluk Sargın

Since Specialization
Citations

This map shows the geographic impact of Haluk Sargın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haluk Sargın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haluk Sargın more than expected).

Fields of papers citing papers by Haluk Sargın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haluk Sargın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haluk Sargın. The network helps show where Haluk Sargın may publish in the future.

Co-authorship network of co-authors of Haluk Sargın

This figure shows the co-authorship network connecting the top 25 collaborators of Haluk Sargın. A scholar is included among the top collaborators of Haluk Sargın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haluk Sargın. Haluk Sargın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gözü, Hülya Ilıksu, Dilek Yavuzer, Handan Kaya, et al.. (2011). Alterations of NIS expression in functioning thyroid nodules.. PubMed. 20(6). 285–92. 1 indexed citations
2.
Şeker, Mesut, Hülya Ilıksu Gözü, Bala Başak Öven Ustaalıoğlu, et al.. (2009). Myasthenia Gravis and Autoimmune Addison Disease in a Patient With Thymoma. Clinical Lung Cancer. 10(5). 367–370. 9 indexed citations
3.
Gözü, Hülya Ilıksu, Sandra Mueller, Rıfat Bircan, et al.. (2008). A New Silent Germline Mutation of the TSH Receptor: Coexpression in a Hyperthyroid Family Member with a Second Activating Somatic Mutation. Thyroid. 18(5). 499–508. 7 indexed citations
4.
Akinci, Fevzi, et al.. (2007). Translation, cultural adaptation, cross-validation of the Turkish diabetes quality-of-life (DQOL) measure. Quality of Life Research. 16(5). 873–879. 37 indexed citations
5.
Akinci, Fevzi, et al.. (2007). Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey. Diabetes Research and Clinical Practice. 79(1). 117–123. 87 indexed citations
6.
Gözü, Hülya Ilıksu, Rıfat Bircan, Knut Krohn, et al.. (2006). Similar prevalence of somatic TSH receptor and Gsα mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. European Journal of Endocrinology. 155(4). 535–545. 49 indexed citations
7.
Sargın, Haluk. (2005). Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?. World Journal of Gastroenterology. 11(37). 5874–5874. 20 indexed citations
8.
Onaran, İlhan, et al.. (2005). Increased glutathione conjugate transport: a possible compensatory protection mechanism against oxidative stress in obesity?. International Journal of Obesity. 30(1). 134–140. 9 indexed citations
9.
Sargın, Haluk, et al.. (2005). The Prevalence of Silent Ischemia in Turkish Patients with Type 2 Diabetes Mellitus. The Tohoku Journal of Experimental Medicine. 205(4). 351–355. 13 indexed citations
10.
Sargın, Mehmet, Haluk Sargın, Asuman Orçun, et al.. (2005). The Effect of Defective Early Phase Insulin Secretion on Postload Glucose Intolerance in Impaired Fasting Glucose. Endocrine Journal. 52(5). 531–536. 5 indexed citations
11.
Sargın, Haluk, Mehmet Sargın, Yüksel Altuntaş, et al.. (2003). Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes. Diabetes Research and Clinical Practice. 62(2). 79–86. 10 indexed citations
12.
Sargın, Mehmet, et al.. (2003). Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance. Journal of Clinical Gastroenterology. 37(5). 399–402. 39 indexed citations
13.
Ati̇lla, Mustafa Kemal, Haluk Sargın, Öner Odabaş, Yüksel Yılmaz, & Sabahattin Aydın. (1998). Evaluation of 42 patients with chronic abacterial prostatitis: Are there any underlying correctable pathologies?. International Urology and Nephrology. 30(4). 463–469. 4 indexed citations
14.
Ati̇lla, Mustafa Kemal, Haluk Sargın, Yüksel Yılmaz, et al.. (1997). Undescended Testes in Adults: Clinical Significance of Resistive Index Values of the Testicular Artery Measured by Doppler Ultrasound as a Predictor of Testicular Histology. The Journal of Urology. 158(3). 841–843. 20 indexed citations
15.
Ati̇lla, Mustafa Kemal, Haluk Sargın, Yüksel Yılmaz, et al.. (1997). Undescended Testes in Adults. The Journal of Urology. 841–843. 1 indexed citations
16.
Burgaz, Sema, et al.. (1996). Serum carotenoids and uric acid levels in relation to cancer. Journal of Clinical Pharmacy and Therapeutics. 21(5). 331–336. 14 indexed citations
17.
Sarıca, Kemal, et al.. (1995). Persistent müllerian duct syndrome: Report of a case with bilateral cryptorchidism. International Urology and Nephrology. 27(4). 431–438.
18.
Gönenç, Aymelek, et al.. (1995). Serum β–carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. Journal of Clinical Pharmacy and Therapeutics. 20(5). 259–263. 48 indexed citations
19.
Sargın, Haluk, et al.. (1995). Serum vitamin E level in patients with breast cancer. Journal of Clinical Pharmacy and Therapeutics. 20(3). 173–178. 12 indexed citations
20.
Sargın, Haluk, et al.. (1994). Evaluation of serum ß-carotene levels in patients with cardiovascular diseases. Journal of Clinical Pharmacy and Therapeutics. 19(1). 61–63. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Bohdanowicz-Pawlak Breakdown of academic impact, for papers by Mary F. Carroll Breakdown of academic impact, for papers by Welmoed Reitsma Breakdown of academic impact, for papers by Göksün Ayvaz Breakdown of academic impact, for papers by L Misso Breakdown of academic impact, for papers by Russo Russo Breakdown of academic impact, for papers by Renata Saucedo Breakdown of academic impact, for papers by Glenn Matfin Breakdown of academic impact, for papers by Hala Ahmadieh Breakdown of academic impact, for papers by Stylianos Kandarakis
Rankless by CCL
2026